A research team at the Massachusetts Institute of Technology (MIT) in the US have advanced a Covid-19 vaccine candidate into preclinical tests in animal models. Led by professor Christopher Love from MIT’s Koch Institute for Iterative Cancer Research, the team worked to develop preclinical materials for rapid progress of the candidate to clinical trials.
